Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more about our disclaimer.
Oncotarget. 2016 Mar 15; 7(11): 12089–12101.
Published online 2016 Feb 25. doi: 10.18632/oncotarget.7725
PMCID: PMC4914271
PMID: 26933811

